Heyholder

DongKoo Bio & Pharma Co., Ltd. Disclosures

006620 · KOSDAQ

Disclosures

4 total · 20 per page

Newest first

Report on Large Shareholdings

Cho Yong-jun's holding ratio stays at 37.18% after partial repayment of a secured loan; pledged shares total 7,547,139, running until the pledge is released.

Major

Share Cancellation

Dongkoo Bio & Pharma will cancel 822,134 treasury common shares, worth KRW 3.0 billion, on November 10, 2026.

20261028000134

Dongkoo Bio & Pharma will terminate its KRW 3.0 billion treasury share trust early on Oct 28, 2026, after acquiring 822,134 shares.

Catch the next disclosure fast

Get app alerts for new disclosures from DongKoo Bio & Pharma Co., Ltd..